TWISTing an embryonic transcription factor into an oncoprotein

Oncogene

Volumn 29, Issue 22, 2010, Pages 3173-3184

  Ansieau, S ^a   Morel, A P ^a   Hinkal, G ^a   Bastid, J ^a,b   Puisieux, A ^a,b  

^a CENTRE LÉON BÉRARD   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Cell dissemination; Embryogenesis; EMT; Failsafe program escape; TWIST

Indexed keywords

CISPLATIN; DAUNORUBICIN; ONCOPROTEIN; PACLITAXEL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TWIST; VINCRISTINE;

CARCINOGENESIS; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ANIMAL; EMBRYONIC STEM CELL; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; EMBRYONIC STEM CELLS; HUMANS; ONCOGENE PROTEINS; TWIST TRANSCRIPTION FACTOR;

EID: 77953228964     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.92     Document Type: Review

References (150)

1. Alborzi A, Mac K, Glackin CA, Murray SS, Zernik JH. (1996) Endochondral and intramembranous fetal bone development: osteoblastic cell proliferation, and expression of alkaline phos-phatase, m-twist, and histone H4. J Craniofac Genet Dev Biol 16: 94-106.
2. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, et al. (2008a). Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14: 79-89.
3. Ansieau S, Hinkal G, Thomas C, Bastid J, Puisieux A. (2008b). Early origin of cancer metastases: dissemination and evolution of premalignant cells. Cell Cycle 7: 3659-3663.
4. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870.
5. Bate M, Rushton E, Currie DA. (1991). Cells with persistent twist expression are the embryonic precursors of adult muscles in Drosophila. Development 113: 79-89.
6. Baum B, Settleman J, Quinlan MP. (2008). Transitions between epithelial and mesenchymal states in development and disease Semin Cell Dev Biol 19: 294-308.
7. Baylies MK, Bate M. (1996). twist: a myogenic switch in Drosophila. Science 272: 1481-1484.
8. Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N et al. (2004) A twist code determines the onset of osteoblast differentiation. Dev Cell 6: 423-435.
9. Bourgeois P, Bolcato-Bellemin AL, Danse JM, Bloch-Zupan A, Yoshiba K, Stoetzel C et al. (1998). The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum Mol Genet 7: 945-957.
10. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B et al. (2005). Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665.
11. Brouzes E, Supatto W, Farge E. (2004). Is mechano-sensitive expression of twist involved In mesoderm formation? Biol Cell 96: 471-477.
12. Butcher DT, Alliston T, Weaver VM. (2009). A tense situation: forcing tumour progression. Nat Rev Cancer 9: 108-122.
13. Castanon I, Von SS, Kass J, Baylies MK. (2001). Dimerization partners determine the activity of the Twist bHLH protein during Drosophila mesoderm development. Development 128: 3145-3159.
14. Cates JM, Dupont WD, Barnes JW, Edmunds HS, Fasig JH, Olson SJ et al. (2008). Markers of epithelial-mesenchymal transition and epithelial differentiation in sarcomatoid carcinoma: utility in the differential diagnosis with sarcoma. Appl Immunohistochem Mol Morphol 16: 251-262.
15. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. (2005). Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730.
16. Chen ZF, Behringer RR. (1995). twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 9: 686-699.
17. Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. (2007) Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67: 1979-1987.
18. Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, Mansour M et al. (2008). Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. J Biol Chem 283: 14665-14673.
19. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M et al. (2005). Tumour biology: senescence in premalignant tumours. Nature 436: 642.
20. Connerney J, Andreeva V, Leshem Y, Mercado MA, Dowell K, Yang X et al. (2008). Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev Biol 318: 323-334.
21. Connerney J, Andreeva V, Leshem Y, Muentener C, Mercado MA, Spicer DB. (2006). Twist1 dimer selection regulates cranial suture patterning and fusion. Dev Dyn 235: 1345-1357.
22. Cripps RM, Olson EN. (1998). Twist is required for muscle template splitting during adult Drosophila myogenesis. Dev Biol 203: 106-115.
23. Demontis S, Rigo C, Piccinin S, Mizzau M, Sonego M, Fabris M et al. (2006). Twist is substrate for caspase cleavage and proteasome-mediated degradation. Cell Death Differ 13: 335-345.
24. Desprat N, Supatto W, Pouille PA, Beaurepaire E, Farge E. (2008). Tissue deformation modulates twist expression to determine anterior midgut differentiation in Drosophila embryos. Dev Cell 15: 470-477.
25. Di CE, Diodoro MG, Boggio K, Modesti A, Modesti M, Nanni P et al. (1999). Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. Lab Invest 79: 1261-1269.
26. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN et al. (2009). Association of reactive oxygen species levels and radio-resistance in cancer stem cells. Nature 458: 780-783.
27. Dong YF, Soung DY, Chang Y, Enomoto-Iwamoto M, Paris M, O'Keefe RJ et al. (2007). Transforming growth factor-beta and Wnt signals regulate chondrocyte differentiation through Twist1 in a stage-specific manner. Mol Endocrinol 21: 2805-2820.
28. Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B et al. (2009). Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 10: 778-785.
29. Dumont N, Wilson MB, Crawford YG, Reynolds PA, Sigaroudinia M, Tlsty TD. (2008). Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci USA 105: 14867-14872.
30. el Ghouzzy V, Le Merrier M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D et al. (1997). Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15: 42-46.
31. Elias MC, Tozer KR, Silber JR, Mikheeva S, Deng M, Morrison RS et al. (2005). TWIST is expressed in human gliomas and promotes invasion. Neoplasia 7: 824-837.
32. Entz-Werle N, Stoetzel C, Berard-Marec P, Kalifa C, Brugiere L, Pacquement H et al. (2005). Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas. Int J Cancer 117: 349-355.
33. Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D et al. (2009). Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 15: 402-415.
34. Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K et al. (2003). DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer 107: 970-975.
35. Farge E. (2003). Mechanical induction of twist in the drosophila foregut/stomodeal primordium. Curr Biol 13: 1365-1377.
36. Fendrich V, Waldmann J, Feldmann G, Schlosser K, Konig A, Ramaswamy A et al. (2009). Unique expression pattern of the EMT markers snail, twist and E-cadherin in benign and malignant parathyroid neoplasia. Eur J Endocrinol 160: 695-703.
37. Feng Y, Zhou YM, Hua CG, Tang XF, He DQ. (2009). Expression of Twist in different subtype of ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108: 565-570.
38. Firulli AB, Conway SJ. (2008). Phosphoregulation of Twist1 provides a mechanism of cell fate control. Curr Med Chem 15: 2641-2647.
39. Firulli BA, Krawchuk D, Centonze VE, Vargesson N, Virshup DM, Conway SJ et al. (2005). Altered Twist1 and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities. Nat Genet 37: 373-381.
40. Fondrevelle ME, Kantelip B, Reiter RE, Chopin DK, Thiery JP, Monnien F et al. (2009). The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol 27: 268-276.
41. Gee HE, Camps C, Buffa FM, Colella S, Sheldon H, Gleadle JM et al. (2008). MicroRNA-10b and breast cancer metastasis. Nature 455: E8-E9.
42. Gong XQ, Li L. (2002). Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. J Biol Chem 277: 12310-12317.
43. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T et al. (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913. (Pubitemid 40559004)
44. Gort EH, Suijkerbuijk KP, Roothaan SM, Raman V, Vooijs M, van der WE et al. (2008a). Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer. Cancer Epidemiol Biomarkers Prev 17: 3325-3330.
45. Gort EH, van HG, Verlaan I, Groot AJ, Plasterk RH, Shvarts A et al. (2008b). The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene 27: 1501-1510.
46. Gripp KW, Zackai EH, Stolle CA. (2000). Mutations in the human TWIST gene. Hum Mutat 15: 150-155.
47. Gupta PB, Chaffer CL, Weinberg RA. (2009a). Cancer stem cells: mirage or reality? Nat Med 15: 1010-1012.
48. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA et al. (2009b). Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659.
49. Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY et al. (1999). Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96: 405-413.
50. Hamamori Y, Wu HY, Sartorelli V, Kedes L. (1997). The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist. Mol Cell Biol 17: 6563-6573.
51. Hasselblatt M, Mertsch S, Koos B, Riesmeier B, Stegemann H, Jeibmann A et al. (2009). TWIST-1 is overexpressed in neoplastic choroid plexus epithelial cells and promotes proliferation and invasion. Cancer Res 69: 2219-2223.
52. Hayashi M, Nimura K, Kashiwagi K, Harada T, Takaoka K, Kato H et al. (2007). Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling. J Cell Sci 120: 1350-1357.
53. Hebrok M, Wertz K, Fuchtbauer EM. (1994). M-twist is an inhibitor of muscle differentiation. Dev Biol 165: 537-544.
54. Hinoi E, Bialek P, Chen YT, Rached MT, Groner Y, Behringer RR et al. (2006). Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev 20: 2937-2942.
55. Hiscox S, Jiang WG, Obermeier K, Taylor K, Morgan L, Burmi R et al. (2006). Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphor-ylation. Int J Cancer 118: 290-301.
56. Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A et al. (2004). Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64: 5270-5282.
57. Hopwood ND, Pluck A, Gurdon JB. (1989). A Xenopus mRNA related to Drosophila twist is expressed in response to induction in the mesoderm and the neural crest. Cell 59: 893-903.
58. Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, Furukawa M et al. (2007). Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res 67: 1970-1978.
59. Hosono S, Kajiyama H, Terauchi M, Shibata K, Ino K, Nawa A et al. (2007). Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. Br J Cancer 96: 314-320.
60. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG. (2007). Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 13: 4769-4776.
61. Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz de Luna RI et al. (1997). Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 15: 36-41.
62. Hu L, Roth JM, Brooks P, Ibrahim S, Karpatkin S. (2008). Twist is required for thrombin-induced tumor angiogenesis and growth. Cancer Res 68: 4296-4302.
63. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E et al. (2008). Systemic spread is an early step in breast cancer. Cancer Cell 13: 58-68.
64. Isenmann S, Arthur A, Zannettino AC, Turner JL, Shi S, Glackin CA et al. (2009). TWIST Family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells 27: 2457-2468.
65. Kajiyama H, Hosono S, Terauchi M, Shibata K, Ino K, Yamamoto E et al. (2006). Twist expression predicts poor clinical outcome of patients with clear cell carcinoma of the ovary. Oncology 71: 394-401.
66. Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A et al. (2007). Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 31: 277-283.
67. Kojc N, Zidar N, Gale N, Poljak M, Fujs KK, Cardesa A et al. (2009). Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck. Virchows Arch 454: 549-555.
68. Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. (2009). Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15: 195-206.
69. Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C, Zhang X et al. (2005). Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 65: 5153-5162.
70. Kyo S, Sakaguchi J, Ohno S, Mizumoto Y, Maida Y, Hashimoto M et al. (2006). High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 37: 431-438.
71. Lee MS, Lowe GN, Strong DD, Wergedal JE, Glackin CA. (1999). TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 75: 566-577.
72. Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH et al. (2006). Twist overexpression correlates with hepatocellular carcino-ma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 12: 5369-5376.
73. Lee YB, Bantounas I, Lee DY, Phylactou L, Caldwell MA, Uney JB. (2009). Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res 37: 123-128.
74. Lee YM, Park T, Schulz RA, Kim Y. (1997). Twist-mediated activation of the NK-4 homeobox gene in the visceral mesoderm of Drosophila requires two distinct clusters of E-box regulatory elements. J Biol Chem 272: 17531-17541.
75. Lee YS, Dutta A. (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025-1030.
76. Li CH, Chen XP, Xu ZQ, Li GP, Guan J. (2006). Expression of Twist gene in human hepatocellular carcinoma and its clinicopathological significance. Zhonghua Wai Ke Za Zhi 44: 1353-1356.
77. Li L, Cserjesi P, Olson EN. (1995). Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev Biol 172: 280-292.
78. Liu Y, El-Naggar S, Darling DS, Higashi Y, Dean DC. (2008). Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 135: 579-588.
79. Lombaerts M, van WT, Philippo K, Dierssen JW, Zimmerman RM, Oosting J et al. (2006). E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 94: 661-671.
80. Ma L, Teruya-Feldstein J, Weinberg RA. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
81. Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L et al. (1999). Twist is a potential oncogene that inhibits apoptosis. Genes Dev 13: 2207-2217.
82. Man TK, Chintagumpala M, Visvanathan J, Shen J, Perlaky L, Hicks J et al. (2005). Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Res 65: 8142-8150.
83. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
84. Martin TA, Goyal A, Watkins G, Jiang WG. (2005). Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 12: 488-496.
85. Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Tanaka S et al. (2009). Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 9: 240.
86. Mayr C, Hemann MT, Bartel DP. (2007). Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576-1579.
87. Mironchik Y, Winnard Jr PT, Vesuna F, Kato Y, Wildes F, Pathak AP et al. (2005). Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 65: 10801-10809.
88. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ et al. (2005). The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197-209.
89. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. (2008). Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3: e2888.
90. Nakaya Y, Sheng G. (2008). Epithelial to mesenchymal transition during gastrulation: an embryological view. Dev Growth Differ 50: 755-766.
91. Nierodzik ML, Karpatkin S. (2006). Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10: 355-362.
92. Niesner U, Albrecht I, Janke M, Doebis C, Loddenkemper C, Lexberg MH et al. (2008). Autoregulation of Th1-mediated inflammation by twist1. J Exp Med 205: 1889-1901.
93. Nieto MA. (2002). The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-166.
94. Nieto MA, Sargent MG, Wilkinson DG, Cooke J. (1994). Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 264: 835-839.
95. Niu RF, Zhang L, Xi GM, Wei XY, Yang Y, Shi YR et al. (2007). Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 26: 385-394.
96. Ohuchida K, Mizumoto K, Ohhashi S, Yamaguchi H, Konomi H, Nagai E et al. (2007). Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. Int J Cancer 120: 1634-1640.
97. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T et al. (1993). Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701.
98. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. (2008). Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654.
99. Ou DL, Chien HF, Chen CL, Lin TC, Lin LI. (2008). Role of Twist in head and neck carcinoma with lymph node metastasis. Anticancer Res 28: 1355-1359.
100. Pan D, Fujimoto M, Lopes A, Wang YX. (2009). Twist-1 is a PPARdelta-inducible, negative-feedback regulator of PGC-1alpha in brown fat metabolism. Cell 137: 73-86.
101. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B et al. (2007). Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6: 2585-2590.
102. Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, Kuntzen C et al. (2007). Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs. Mol Cell Biol 27: 3920-3935.
103. Polyak K, Weinberg RA. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
104. Puisieux A, Valsesia-Wittmann S, Ansieau S. (2006). A twist for survival and cancer progression. Br J Cancer 94: 13-17.
105. Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II, Yang SH et al. (2009). Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. Lung Cancer 63: 219-226.
106. Rice DP, Aberg T, Chan Y, Tang Z, Kettunen PJ, Pakarinen L et al. (2000). Integration of FGF and TWIST in calvarial bone and suture development. Development 127: 1845-1855.
107. Rodrigues CO, Nerlick ST, White EL, Cleveland JL, King ML. (2008). A Myc-Slug (Snail2)/Twist regulatory circuit directs vascular development. Development 135: 1903-1911.
108. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R et al. (2002). Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 161: 1881-1891.
109. Satoh K, Hamada S, Kimura K, Kanno A, Hirota M, Umino J et al. (2008). Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells. Am J Pathol 172: 926-939.
110. Schardt JA, Meyer M, Hartmann CH, Schubert F, Schmidt-Kittler O, Fuhrmann C et al. (2005). Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 8: 227-239.
111. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. (1991). E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337.
112. Sharabi AB, Aldrich M, Sosic D, Olson EN, Friedman AD, Lee SH et al. (2008). Twist-2 controls myeloid lineage development and function. PLoS Biol 6: e316.
113. Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN et al. (2006). Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 203: 1891-1901.
114. Shibata K, Kajiyama H, Ino K, Terauchi M, Yamamoto E, Nawa A et al. (2008). Twist expression in patients with cervical cancer is associated with poor disease outcome. Ann Oncol 19: 81-85.
115. Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A et al. (2008). Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene. 27: 5543-5553.
116. Smit MA, Peeper DS. (2008). Deregulating EMT and senescence: double impact by a single twist. Cancer Cell 14: 5-7.
117. Smit MA, Geiger TR, Song JY, Gitelman I, Peeper DS. (2009). A Twist-Snail axis critical for TrkN-induced epithelial-mesenchymal transition-like transformation, anoikis resistance and metastasis. Mol Cell Biol 29: 3722-3729.
118. Song LB, Liao WT, Mai HQ, Zhang HZ, Zhang L, Li MZ et al. (2006). The clinical significance of twist expression in nasophar-yngeal carcinoma. Cancer Lett 242: 258-265.
119. Sosic D, Richardson JA, Yu K, Ornitz DM, Olson EN. (2003). Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 112: 169-180.
120. Spicer DB, Rhee J, Cheung WL, Lassar AB. (1996). Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 272: 1476-1480.
121. Stasinopoulos IA, Mironchik Y, Raman A, Wildes F, Winnard Jr P, Raman V. (2005). HOXA5-twist interaction alters p53 homeostasis in breast cancer cells. J Biol Chem 280: 2294-2299.
122. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
123. Thisse B, el MM, Perrin-Schmitt F. (1987). The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res 15: 3439-3453.
124. Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin CH, Moustakas A. (2006). Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 174: 175-183.
125. Trimboli AJ, Fukino K, de BA, Wei G, Shen L, Tanner SM et al. (2008). Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 68: 937-945.
126. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO et al. (1994). Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54: 3929-3933.
127. Valdes-Mora F, Gomez del PT, Bandres E, Cejas P, Ramirez de MA, Perez-Palacios R et al. (2009). TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer. Ann Surg Oncol 16: 78-87.
128. Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V et al. (2004). Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 6: 625-630.
129. Vesuna F, van Dienst P, Chen JH, Raman V. (2008). Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 367: 235-241.
130. Waldmann J, Slater EP, Langer P, Buchholz M, Ramaswamy A, Walz MK et al. (2009). Expression of the transcription factor snail and its target gene twist are associated with malignancy in pheochromocy-tomas. Ann Surg Oncol 16: 1997-2005.
131. Wang SM, Coljee VW, Pignolo RJ, Rotenberg MO, Cristofalo VJ, Sierra F. (1997). Cloning of the human twist gene: its expression is retained in adult mesodermally-derived tissues. Gene 187: 83-92.
132. Wang X, Ling MT, Guan XY, Tsao SW, Cheung HW, Lee DT et al. (2004). Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene 23: 474-482.
133. Watanabe O, Imamura H, Shimizu T, Kinoshita J, Okabe T, Hirano A et al. (2004). Expression of twist and wnt in human breast cancer. Anticancer Res 24: 3851-3856.
134. Whitehead J, Vignjevic D, Futterer C, Beaurepaire E, Robine S, Farge E. (2008). Mechanical factors activate beta-catenin-dependent oncogene expression in APC mouse colon. HFSP J 2: 286-294.
135. Wolf C, Thisse C, Stoetzel C, Thisse B, Gerlinger P, Perrin-Schmitt F. (1991). The M-twist gene of Mus is expressed in subsets of mesodermal cells and is closely related to the Xenopus X-twi and the Drosophila twist genes. Dev Biol 143: 363-373.
136. Wong MC, Castanon I, Baylies MK. (2008). Daughterless dictates Twist activity in a context-dependent manner during somatic myogenesis. Dev Biol 317: 417-429.
137. Xie F, Li K, Ouyang X. (2009). Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients. Clin Exp Metastasis 26: 1025-1032.
138. Xie S, Wu H, Wang Q, Cogswell JP, Husain I, Conn C et al. (2001). Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J Biol Chem 276: 43305-43312.
139. Xu J, Chen X. (2007). Expression of twist gene in primary liver cancer. J Huazhong Univ Sci Technolog Med Sci 27: 668-670.
140. Yan-Qi Z, Xue-Yan G, Shuang H, Yu C, Fu-Lin G, Fei-Hu B et al. (2007). Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer. Pathology 39: 470-475.
141. Yang AD, Fan F, Camp ER, Van BG, Liu W, Somcio R et al. (2006). Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12: 4147-4153.
142. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY et al. (2009). Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50: 1464-1474.
143. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
144. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ et al. (2008). Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10: 295-305.
145. Yin Z, Xu XL, Frasch M. (1997). Regulation of the twist target gene tinman by modular cis-regulatory elements during early mesoderm development. Development 124: 4971-4982.
146. Yoshida J, Horiuchi A, Kikuchi N, Hayashi A, Osada R, Ohira S et al. (2009). Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression. Med Mol Morphol 42: 82-91.
147. Yuen HF, Chan YP, Wong ML, Kwok WK, Chan KK, Lee PY et al. (2007). Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis. J Clin Pathol 60: 510-514.
148. Zhang Z, Xie D, Li X, Wong YC, Xin D, Guan XY et al. (2007). Significance of TWIST expression and its association with E-cadherin in bladder cancer. Hum Pathol 38: 598-606. (Pubitemid 46399887)
149. Zhu Q, Xu H, Xu Q, Yan W, Tian D. (2008). Expression of Twist gene in human hepatocellular carcinoma cell strains of different metastatic potential. J Huazhong Univ Sci Technolog Med Sci 28: 144-146.
150. Zhuo WL, Wang Y, Zhuo XL, Zhang YS, Chen ZT. (2008). Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway. Biochem Biophys Res Commun 369: 1098-1102.